成年患者心房隔膜缺陷后的长期结果
Han Zhang1, Gang Li1, Jiashu Sun1
1Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Annals of medicine
|September 12, 2025
概括
患有心房隔膜缺陷 (AVSD) 修复的成年人表现出安全的结果,早期死亡率低,长期结果良好. 密切监测心律失常是至关重要的,尽管重复手术率很低.
科学领域:
- 心脏病学 心脏病学
- 成年人的先天性心脏病
- 心脏外科手术 心脏外科手术
背景情况:
- 心房隔膜缺陷 (AVSD) 是一种先天性心脏异常.
- 成年患者的手术修复带来了独特的挑战和结果.
研究的目的:
- 评估成年患者中心室隔膜缺陷 (AVSD) 修复的早期和长期结果.
- 评估AVSD修复在当代成人队列中的安全性和有效性.
主要方法:
- 对168名在2013年至2023年期间接受AVSD修复的成年患者的回顾性分析.
- 数据收集包括人口统计,缺陷类型,手术程序和早期/晚期结果.
- 随访的重点是死亡率,重新手术和功能恢复.
主要成果:
- 手术时的平均年龄为36.4岁;87.5%的人患有部分AVSD.
- 早期死亡率很低 (2人死亡). 观察到心脏测量,肺动脉压力和门吐的显著恢复.
- 没有重新干预的10年生存率为74.7%,心律失常是重新手术的常见原因 (91.2%).
结论:
- 成年人的心房隔膜缺陷 (AVSD) 修复与较低的早期死亡率和有利的长期结果有关.
- 虽然重复手术率较低,但对手术后心律失常的警监测对于最佳的患者管理至关重要.
更多相关视频
07:41Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
4.3K
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
19.2K
相关概念视频
Cardiomyopathy V: Interprofessional Care
343
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
343
Mitral Stenosis III: Medical Management
249
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
249
Mitral Stenosis I: Introduction
485
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
485
Aortic Regurgitation III: Medical Management
401
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
401
Mitral Regurgitation III: Medical Management
284
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
284
